Home Overview Press Room Blog Publications For Students about us
Search

About Biopolitics, Parties, Pundits & Human Biotechnology


Policy decisions about human biotechnologies have typically been debated among elite commissions and experts. But controversy is increasingly spilling over into mainstream news media and political debates.

This trend has been most notable in the United States, with the emergence of human embryonic stem cell research as a political issue. Stem cell debates at the policy level have made this discussion far more visible to the public.

The Bush Administration's restrictions on federal funding for human embryonic stem cell research elevated the issue to the front pages of newspapers. Shortly after its announcement in 2001, partisan battle lines were drawn in ways that mirror the abortion rights divide.

Republicans hoped that opposition to research that destroys embryos would increase support among their party's religious conservative base. Democrats countered by assembling a coalition of patient advocates, biomedical researchers, and biotechnology entrepreneurs and appealed to moderate swing voters and Republicans who they believed would be swayed by promises of cures.

There were some notable exceptions to this partisan line-up. Some conservatives support embryonic stem cell research; some liberals and progressives who support the research in principle criticize aspects of its conduct and regulation. Unfortunately, the polarized debate has frequently distorted facts while obscuring a range of important social issues unrelated to the moral status of embryos.



CGS Board Member Leads Redress Call for California Survivors of Eugenic Sterilization by Marcy DarnovskyJanuary 16th, 2017Scholars estimate that more than 800 people alive today were sterilized in California state institutions, and call on the state to consider compensation and redress.
Obama vs. Trump: 5 ways they clash — or don’t — on health and scienceby Dylan ScottSTATJanuary 9th, 2017While Trump might play some wild cards in medicine, science, and public health, there may be some surprising continuity with President Obama’s administration.
How Gene Editing Could Ruin Human Evolution[cites CGS's Marcy Darnovsky]by Jim KozubekTimeJanuary 9th, 2017There are no superior genes. Genes have a long and layered history, and they often have three or four unrelated functions, which balance against each other under selection.
Designer babies: an ethical horror waiting to happen?by Philip BallThe Guardian January 8th, 2017A perfectly feasible 10-20% improvement in health via PGD, added to the comparable advantage that wealth already brings, could lead to a widening of the health gap between rich and poor, both within a society and between nations.
Philippine police arrest surrogate mothers-to-be in human trafficking crackdownby Lindsay MurdochSydney Morning HeraldJanuary 4th, 2017International surrogacy agents operate across multiple borders, flying surrogates, eggs, doctors and parents to whichever country is the most porous for their business.
2016 Fear vs Hope: Gene Editing— Terrible turning point?by Pete ShanksDeccan ChronicleJanuary 1st, 2017As the tools for gene editing rapidly advance, we approach our best chance to prevent the rise of a modern, uncontrolled and dangerously ill-considered techno-eugenics.
Unexpected Risks Found In Replacing DNA To Prevent Inherited Disordersby Jill NeimarkNPRJanuary 1st, 2017Scientists are increasingly concerned that "3-person IVF" techniques may allow flawed mitochondria to resurface and threaten a child's health.
China’s $9 billion effort to beat the U.S. in genetic testing[cites CGS's Marcy Darnovsky]by Ylan Q. MuiWashington PostDecember 30th, 2016Chinese investors — both private and government-supported — are backing American start-ups and funding promising new companies at home.
Will the Alt-Right Promote a New Kind of Racist Genetics?by Sarah ZhangThe AtlanticDecember 29th, 2016The genomic revolution has led to easy sequencing and cheap "ancestry" tests. White nationalists are paying attention.
Lawmakers try to fix a side effect of reducing drug and theft crimes: Not enough DNA samples for cold casesby Jazmine UlloaLos Angeles TimesDecember 22nd, 2016A California bill would expand the state's DNA database, raising serious concerns about privacy and disproportionately targeting blacks and Latinos.
Displaying 1-10 of 1554  
Next >> 
Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1122 University Ave, Suite 100, Berkeley, CA 94702 • • (p) 1.510.665.7760 • (F) 1.510.665.8760